Colorectal cancer screening: Clinical Practice Guidelines in oncology™

Bernard Levin, James S. Barthel, Randall W. Burt, Donald S. David, James M. Ford, Francis M. Giardiello, Stephen B. Gruber, Amy L. Halverson, Stanley Hamilton, Wendy Kohlmann, Kirk A. Ludwig, Patrick M. Lynch, Christopher Marino, Edward W. Martin, Robert J. Mayer, Boris Pasche, Samuel J. Pirruccello, Ashwani Rajput, M. Sambasiva Rao, Moshe ShikeGideon Steinbach, Jonathan P. Terdiman, David Weinberg, Sidney J. Winawer

Research output: Contribution to journalReview articlepeer-review

33 Scopus citations


Colorectal cancer is the third most frequently diagnosed cancer in men and women in the United States. An estimated 104,950 new cases of colon cancer and 40,340 new cases of rectal cancer will occur in the United States in 2005. During the same year, an estimated 56,290 people will die from colon and rectal cancer. Because patients with localized colon cancer have a 90% 5-year survival rate, screening is a critical and particularly effective procedure for colorectal cancer prevention. Screening options include colonoscopy; combined fecal occult blood test (FOBT) and sigmoidoscopy; sigmoidoscopy alone; or double-contrast barium enema.

Original languageEnglish (US)
Pages (from-to)384-420
Number of pages37
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number4
StatePublished - Apr 2006


  • APC
  • Adenoma
  • Colorectal cancer
  • FAP
  • Fecal occult blood test
  • NCCN Clinical Practice Guidelines

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Colorectal cancer screening: Clinical Practice Guidelines in oncology™'. Together they form a unique fingerprint.

Cite this